Functional and haemodynamic recovery after implantation of continuous-flow left ventricular assist devices in comparison with pulsatile left ventricular assist devices in patients with end-stage heart failure

European Journal of Heart Failure

Volumn 14, Issue 3, 2012, Pages 319-325

  Pruijsten, Ralph V ^a   Lok, Sjoukje I ^a   Kirkels, Hans H ^a   Klöpping, Corinne ^a   Lahpor, Jaap R ^a   De Jonge, Nicolaas ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Heart failure; Heart transplantation; Ventricular assist device

Indexed keywords

ALBUMIN; ALKALINE PHOSPHATASE; BRAIN NATRIURETIC PEPTIDE; CREATININE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; HEMOGLOBIN; SODIUM; UREA;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICE; CONVALESCENCE; CREATININE BLOOD LEVEL; DAILY LIFE ACTIVITY; ECHOCARDIOGRAPHY; EXERCISE; FEMALE; FUNCTIONAL STATUS; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HEART FAILURE; HEART HEMODYNAMICS; HEART RATE; HEART TRANSPLANTATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; IMPLANTATION; INTERMETHOD COMPARISON; INTERNATIONAL NORMALIZED RATIO; LABORATORY TEST; LEFT VENTRICULAR ASSIST DEVICE; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PULSATILE LEFT VENTRICULAR ASSIST DEVICE; SODIUM BLOOD LEVEL; UREA BLOOD LEVEL; VENOUS OXYGEN TENSION;

ADULT; EXERCISE TEST; EXERCISE TOLERANCE; FEMALE; HEART FAILURE; HEART TRANSPLANTATION; HEART VENTRICLES; HEART-ASSIST DEVICES; HEMODYNAMICS; HUMANS; INCIDENCE; MALE; OXYGEN CONSUMPTION; STATISTICS AS TOPIC; TIME FACTORS;

EID: 84857519253     PISSN: 13889842     EISSN: 18790844     Source Type: Journal    
DOI: 10.1093/eurjhf/hfr181     Document Type: Article

References (21)

1. Jaski BE, Lingle RJ, Kim J, Branch KR, Goldsmith R, Johnson MR, Lahpor JR, Icenogle TB, Piña I, Adamson R, Favrot LK, Dembitsky WP. Comparison of functional capacity in patients with end stage heart failure following implantation of a left ventricular assist device versus heart transplantation: results of the experience with left ventricular assist device with exercise trial. J Heart Lung Transplant 1999;18:1031-1040.
2. Chatterjee K. Refractory heart failure-drugs and devices. Eur Heart J 2001;22:2227-2230.
3. Alba AC, McDonald M, Rao V, Ross HJ, Delgado DH. The effect of ventricular assist devices on long-term post-transplant outcomes: a systematic review of observational studies. Eur J Heart Fail 2011;13:785-795.
4. De Jonge N, Kirkels JH, Lahpor JR, Klöpping C, Hulzebos EJ, de la Rivière AB, Robles De Medina EO. Exercise performance in patients with endstage heart failure after implantation of a left ventricular assist device and after heart transplantation; an outlook for permanent assisting? J Am Coll Cardiol 2001;37:1794-1799.
5. Rose EA, Gelijns AC, Moskowitz AJ, Heitjan DF, Stevenson LW, Dembitsky W, Long JW, Ascheim DD, Tierney AR, Levitan RG, Watson JT, Meier P, Ronan NS, Shapiro PA, Lazar RM, Miller LW, Gupta L, Frazier OH, Desvigne-Nickens P, Oz MC, Poirier VL; Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH). Longterm use of a left ventricular assist device for end-stage heart failure. N Engl J Med 2001;345:1435-1443.
6. Bruggink AH, van Oosterhout MF, de Jonge N, Ivangh B, van Kuik J, Voorbij RH, Cleutjens JP, Gmelig-Meyling FH, de Weger RA. Reverse remodeling of the myocardial extracellular matrix after prolonged left ventricular assist device support follows a biphasic pattern. J Heart Lung Transplant 2006;25:1091-1098.
7. Pruijsten RV, de Jonge N, Kirkels JH, Klöpping C, Doevendans PA, Oosterom A, Kemperman H, Lahpor JR. Left ventricular assist device: a functional comparison with heart transplantation. Neth Heart J 2008;16:41-46.
8. Slaughter MS, Rogers JG, Milano CA, Russell SD, Conte JV, Feldman D, Sun B, Tatooles AJ, Delgado RM 3rd, Long JW, Wozniak TC, Ghumman W, Farrar DJ, Frazier OH; Heart Mate II Investigators. Advanced heart failure treated with continuous-flow left ventricular assist device. N Engl J Med 2009;361:2241-2251.
9. Haft J, Armstrong W, Dyke DB, Aaronson KD, Koelling TM, Farrar DJ, Pagani FD. Hemodynamic and exercise performance with pulsatile and continuous-flow left ventricular assist devices. Circulation 2007;116 [suppl I] I-8-I-15.
10. Jakovljevic DG, George RS, Nunan D, Donovan G, Bougard RS, Yacoub MH, Birks EJ, Brodie DA. The impact of acute reduction of continuous-flow left ventricular assist device support on cardiac and exercise performance. Heart 2010;96:1390-1395.
11. Stevenson LW, Pagani FD, Young JB, Jessup M, Miller L, Kormos RL, Naftel DC, Ulisney K, Desvigne-Nickens P, Kirklin JK. INTERMACS profiles of advanced heart failure: the current picture. J Heart Lung Transplant 2009;28:535-541.
12. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717.
13. Vrtovec B, Radovancevic R, Delgado RM, Radovancevic B, Bracey AW, Gregoric ID, Frazier OH. Significance of anaemia in patients with advanced heart failure receiving long-term mechanical circulatory support. Eur J Heart Fail 2009;11:1000-1004.
14. Robbins M, Francis G, Pashkow FJ, Snader CE, Hoercher K, Young JB, Lauer MS. Ventilatory and heart rate responses to exercise: better predictors of heart failure mortality than peak oxygen consumption. Circulation 1999;100:2411-2417.
15. Chua TP, Ponikowski P, Harrington D, Anker SD, Webb-Peploe K, Clark AL, Poole-Wilson PA, Coats AJ. Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure. J Am Coll Cardiol 1997;29:1585-1590.
16. Weber KT, Kinasewitz GT, Janicki JS, Fishman AP. Oxygen utilization and ventilation during exercise in patients with chronic cardiac failure. Circulation 1982;65:1213-1223.
17. Jakovljevic DG, Birks EJ, George RS, Trenell MI, Seferovic PM, Yacoub MH, Brodie DA. Relationship between peak cardiac pumping capability and selected exercise-derived prognostic indicators in patients treated with left ventricular assist devices. Eur J Heart Fail 2011;13:992-999.
18. Woods PR, Bailey KR, Wood CM, Johnson BD. Submaximal exercise gas exchange is an important prognostic tool to predict adverse outcomes in heart failure. Eur J Heart Fail 2011;13:303-310.
19. Rogers JG, Aaronson KD, Boyle AJ, Russell SD, Milano CA, Pagani FD, Edwards BS, Park S, John R, Conte JV, Farrar DJ, Slaughter MS; Heart Mate II Investigators. Continuous flow left ventricular assist device improves functional capacity and quality of life of advanced heart failure patients. J Am Coll Cardiol 2010;55:1826-1834.
20. Allen JG, Weiss ES, Schaffer JM, Patel ND, Ullrich SL, Russell SD, Shah AS, Conte JV. Quality of life and functional status in patients surviving 12 months after left ventricular assist device implantation. J Heart Lung Transplant 2010;29:278-285.
21. Kirkels JH, de Jonge N, Lahpor JR. Assist devices in the new decade: from technical developments to political decisions. Eur J Heart Fail 2010;12:217-218